These were equally distributed between the placebo and active agent group and while there was a tendency to more IBD activity in the placebo group (23.8% vs 12.5%) this did not reach statistical significance ( P = 0.29) (Table 2 ).
← all excerpts
Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel diseases in absence of inflammation (train-IBD trial).
1
0.2900
0.2900